| 0 (0%) | 01-19 18:54 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.1 | 1-year : | 3.62 |
| Resists | First : | 2.65 | Second : | 3.1 |
| Pivot price | 1.07 |
|||
| Supports | First : | 1.43 | Second : | 0.67 |
| MAs | MA(5) : | 1.64 |
MA(20) : | 1.02 |
| MA(100) : | 1.76 |
MA(250) : | 3.48 |
|
| MACD | MACD : | 0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 52.5 |
D(3) : | 59.9 |
| RSI | RSI(14): 63.7 |
|||
| 52-week | High : | 10.39 | Low : | 0.67 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ XAIR ] has closed below upper band by 17.1%. Bollinger Bands are 159.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.14 - 2.16 | 2.16 - 2.17 |
| Low: | 1.42 - 1.43 | 1.43 - 1.44 |
| Close: | 1.68 - 1.7 | 1.7 - 1.72 |
Thu, 15 Jan 2026
XAIR: Second-generation nitric oxide device targets major U.S. and global market share growth - TradingView — Track All Markets
Thu, 15 Jan 2026
XAIR: Second-generation nitric oxide device and global expansion set to accelerate growth - TradingView — Track All Markets
Wed, 14 Jan 2026
US Market Wrap: Is XAIR stock a smart retirement pick - July 2025 Technicals & Stepwise Swing Trade Plans - baoquankhu1.vn
Wed, 14 Jan 2026
Beyond Air (XAIR) Secures $5M Through Private Placement Deal - GuruFocus
Wed, 14 Jan 2026
Beyond Air (XAIR) stock whipsaws after NeuroNOS deal — premarket drop follows 150% rally - TechStock²
Tue, 13 Jan 2026
XAIR Stock More Than Doubled Today — What’s Driving The Rally? - Stocktwits
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 8 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 5.7 (%) |
| Held by Institutions | 20 (%) |
| Shares Short | 293 (K) |
| Shares Short P.Month | 515 (K) |
| EPS | -5.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.59 |
| Profit Margin | 0 % |
| Operating Margin | -421.4 % |
| Return on Assets (ttm) | -49.8 % |
| Return on Equity (ttm) | -178.1 % |
| Qtrly Rev. Growth | 127.8 % |
| Gross Profit (p.s.) | -0.05 |
| Sales Per Share | 0.72 |
| EBITDA (p.s.) | -3.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -24 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | -0.31 |
| PEG Ratio | 0 |
| Price to Book value | 1.06 |
| Price to Sales | 2.34 |
| Price to Cash Flow | -0.58 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|